Polynovo Limited ( (AU:PNV) ) has provided an announcement.
PolyNovo Limited has released a webcast recording of its 1H FY25 results presentation for shareholders and interested parties who missed the live event. This announcement highlights the company’s ongoing commitment to transparency and engagement with stakeholders, as it continues to expand its market presence and product offerings in the medical technology sector.
More about Polynovo Limited
PolyNovo Limited is a medical technology company based in Melbourne, Australia, and is part of the ASX 200. The company specializes in products that simplify the management of acute complex wounds, offering innovative solutions that improve patient outcomes across various wound types. PolyNovo has treated over 67,000 patients in 46 countries and is focused on growth through new products, indications, and market expansion.
YTD Price Performance: 6.73%
Average Trading Volume: 4,170
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $858.3M
See more insights into PNV stock on TipRanks’ Stock Analysis page.